Maravai LifeSciences Holdings, Inc. (MRVI) Net margin 2019–2025
Maravai LifeSciences Holdings, Inc. (MRVI) net profit margin by fiscal year — reported net income divided by reported revenue.
-70.4%FY2025 · since FY2019: -3.1% → -70.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -70.4% | -14.5 pp |
| FY2024 | -55.9% | -14.7 pp |
| FY2023 | -41.2% | -66.1 pp |
| FY2022 | 24.9% | +2.2 pp |
| FY2021 | 22.8% | -8.5 pp |
| FY2020 | 31.3% | +34.4 pp |
| FY2019 | -3.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More MRVI financial trends
MRVI RevenueMRVI Net incomeMRVI Gross profitMRVI Gross marginMRVI Operating incomeMRVI Operating marginMRVI Operating cash flowMRVI Free cash flowMRVI Capital expendituresMRVI Return on equityMRVI Stock buybacksMRVI Dividends paidMRVI Total assetsMRVI Total liabilitiesMRVI Shareholders’ equityMRVI overview →